8 New Drugs for Primary Care: Q2 2020
The first and only non-hormonal gel for pregnancy prevention, the first minocycline product for use in rosacea, and 6 more recently approved drugs of interest to primary care.
Another quarter has ended, which means Patient Care® Online has compiled another list of new FDA-approved drugs for conditions often seen in primary care. Scroll through the slides below to find details on the first nonhormonal, on-demand contraceptive gel; the first ready-to-use glucagon in a premixed autoinjector to treat hypoglycemia; a vaccine against invasive meningococcal disease; and 5 more.
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.
